ClinicalTrials.Veeva

Menu

The Role of the Coagulation Pathways in Recurrent Angioedema (Angiocoag)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Terminated

Conditions

Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency

Treatments

Other: BLOOD TEST

Study type

Interventional

Funder types

Other

Identifiers

NCT02892682
UF 9650

Details and patient eligibility

About

Previous studies reported infraclinical modifications of the homeostasis in chronic urticaria, recurrent idiopathic angioedema and hereditary angioedema. This study aim to compare groups with isolated wheals, isolated angioedema, combination of both and hereditary angioedema in terms of coagulation pathways.

Full description

Previous studies reported infraclinical modifications of the homeostasis in chronic urticaria, recurrent idiopathic angioedema and hereditary angioedema. This study aim to compare groups with isolated wheals, isolated angioedema, combination of both and hereditary angioedema in terms of coagulation pathways. the main objective is to highlight a difference between the rates of different coagulation factors in the 3 groups presenting different categories of angiodemes patients with a group of patients with isolated superficial chronic urticaria

Enrollment

96 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • recurrent angioderma

Exclusion criteria

  • anticoagulant therapy, diseases of hemostasis

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

96 participants in 4 patient groups

Arm 1 AE-Bk
Other group
Description:
Arm of the recurring angiodeme medié by the bradykinine: blood test
Treatment:
Other: BLOOD TEST
Arm 2 AE-Mast
Other group
Description:
Superficial nettle rash group recurring angiodemes associated with superficial nettle rash: blood test
Treatment:
Other: BLOOD TEST
ARM 3 AEI
Other group
Description:
Arm recurring angiodemes isolate idiopathique not hostaminergique: blood test
Treatment:
Other: BLOOD TEST
ARM 4 US
Other group
Description:
Arm of superficial nettle rashes: blood test
Treatment:
Other: BLOOD TEST

Trial contacts and locations

1

Loading...

Central trial contact

NADIA raison-Peyron, MD; Aurélie Du Thanh, MD, Ph D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems